Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

NCT05576623 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
Vaccines

Interventions

BIOLOGICAL: AdCLD-CoV19-1 OMI (Part A)
BIOLOGICAL: AdCLD-CoV19-1 OMI (Part B)
OTHER: Placebo (Part B)

Sponsor

Cellid Co., Ltd.